nach oben

Cancer Immunology, Immunotherapy

Erschienen in:

01.03.2012 | Letter to the editors

Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. ‘HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response’

verfasst von: Andrew M. Jackson, Hester A. Franks

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editors …

Codolo G, Fassan M, Munari F, Volpe A, Bassi P, Rugge M, Pagano F, D’Elios MM, de Bernard M (2011) HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother. doi:10.1007/s00262-011-1087-2

Alexandroff AB, Nicholson S, Patel PM, Jackson AM (2010) Recent advances in BCG immunotherapy in malignancy. Immunotherapy 2:551–560PubMedCrossRef

Alexandroff AB, Jackson AM, O’Donnell MA, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353:1689–1694PubMedCrossRef

Jackson AM, James K (1994) Understanding the most successful immunotherapy for cancer. Immunologist 2:208–215

Luo Y, Henning J, O’Donnell MA (2011) Th1 cytokine secreting recombinant mycobacterium bovis Bacillus Calmette-Guerin and prospective use in immunotherapy of bladder cancer. Clin Dev Immunol. doi:10.1155/2011/728930

Rosevear HM, Lightfoot AJ, Birusingh KK, Maymí JL, Nepple KG, O’Donnell MA, National BCG/interferon investigator group (2011) Factors affecting response to bacillus clamette-gurein plus interferon for urothelial carcinoma in situ. J Urol 186:817–823PubMedCrossRef

de Bernard M, D’Elios MM (2010) The immune modulating activity of Helicobacter pylori HP-NAP: friend or foe? Toxicon 15:1186–1192CrossRef

Gavalas E, Kountouras J, Deretzi G, Boziki M, Zavos C, Venizelos I (2007) Letter to Editor: Helicobacter pylori and multiple sclerosis. J Neuroimmunol 188:187–189

Li W, Minohara M, Piao H, Matsishita T, Masaki K, Matsuoka T, Isobe N, Su JJ, Ohyagi Y, Kira J (2009) Association of anti-Helicobacter pylori neutrophil-activation protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple scleroisis and neuromyelitis optica. Mult Scler 15:1411–1421PubMedCrossRef

10.

Kountouras J et al (2010) Letter to Editor: Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica. Mult Scler 16:376–377

11.

Yool AJ (2007) Aquaporins: multiple roles in the central nervous system. Neuroscientist 13:470–485PubMedCrossRef

12.

Venero JL, Vizuete ML, Machado A, Cano J (2001) Aquaporins in the central nervous system. Prog Neurobiol 63:321–336PubMedCrossRef

13.

Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, Ishizu T, Kira J (2007) Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 184:227–231PubMedCrossRef

14.

Wender M (2003) Prevalence of Helicobacter pylori infection among patients with multiple sclerosis. Neurol Neurochir Pol 37:45–48PubMed

15.

Radic M, Kaliterna DM, Rosic J (2011) Heliocbacter pylori infection and systemic sclerosis—is there a link? Joint Bone Spine 78:337–340PubMedCrossRef

Titel: Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. ‘HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response’
verfasst von: Andrew M. Jackson
Hester A. Franks
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: Cancer Immunology, Immunotherapy / Ausgabe 3/2012
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-011-1144-x

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. ‘HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response’

Excerpt

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany

Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens

A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein

Role of CD44 in lymphokine-activated killer cell-mediated killing of melanoma

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie